. Author manuscript; available in PMC: 2013 May 1.

Published in final edited form as: Am J Med Sci. 2012 May;343(5):371–374. doi: 10.1097/MAJ.0b013e3182514093

Table 2.

TNF utilization in AS or SpA in Different Countries

Country	Year	AS	PsA
Belgium (5)	2009	44%	n.a.
Canada (Toronto)^*	2011	48%	n.a.
Hong Kong (16)	2005-2006	0%	n.a.
Portugal (43)	2011	58%	52%
Spain (9)	2004-2005	17%	12%
Turkey (44)	2010	16.4%	n.a.
United States^*	2011	50-55%	n.a.
Argentina (45)^**	2008	10.4%^*
Brazil (45) ^**	2008	5.4%^*
Chile (45) ^**	2008	0%^*
Costa Rica (45) ^**	2008	10.4%^*
Mexico (45) ^**	2008	12.1%^*
Peru (45) ^**	2008	1.7%^*
Uruguay (45) ^**	2008	0%^*
Venezuela (45) ^**	2008	27%^*

Unpublished data from the Toronto and PSOAS Registries,

^**

Total SpA